PCF Group S.A. approved a capital increase on 10 February 2023 through the issuance of new Series E ordinary bearer shares.
The capital injection is strategically intended to increase PCF Group’s equity stake in its Katowice-based subsidiary, Incuvo S.A.
Existing shareholders have been denied pre-emptive rights to purchase the newly issued Series E shares.
The board is pursuing the formal dematerialisation of the new shares and their subsequent listing on the Warsaw Stock Exchange.
The issuance requires a statutory amendment to the company’s articles to formally incorporate the new Series E share class.
This corporate action follows the company's previously disclosed intent to strengthen its financial position and investment in Incuvo S.A. as outlined in report No. 2/2023.
The report announces that on 10 February 2023 the board of PCF Group S.A., headquartered in Warsaw, approved a capital‑increase resolution. The increase will be executed through the issuance of new ordinary bearer shares, Series E, which will not grant existing shareholders a pre‑emptive right to purchase all new shares. The resolution also seeks approval for listing the new shares on the regulated market of the Warsaw Stock Exchange, dematerialisation of the shares, and a statutory amendment to incorporate the new share class. The decision follows earlier communication in report No. 2/2023, where the board disclosed plans to deepen PCF Group’s equity stake in its subsidiary Incuvo S.A., based in Katowice. The new capital injection is intended to support this strategic investment and enhance the group’s financial position.
Key points include: a targeted capital increase via Series E ordinary shares; denial of pre‑emptive rights to current shareholders; application for market listing and dematerialisation; statutory changes to the company’s articles. The resolution is governed by Polish financial regulation, specifically § 5(9) and § 14(1‑2) of the Minister of Finance regulation dated 29 March 2018. The report is a routine disclosure under the Polish regulatory framework, providing shareholders and market participants with timely information on significant corporate actions.